Left Menu
Development News Edition

China extends emergency use of its coronavirus vaccines to three more cities

China in a surprise move on October 9 joined the WHO's COVAX alliance to equitably distribute COVID-19 ending speculation that it plans to supply its vaccines to developing countries to improve its image dented by pandemic since it emerged in Wuhan in December last year. All the 11 vaccines in China are in various stages of trials and await final approval.

PTI | Beijing | Updated: 18-10-2020 20:23 IST | Created: 18-10-2020 20:04 IST
China extends emergency use of its coronavirus vaccines to three more cities
Representative Image Image Credit: ANI

Days after joining the World Health Organisation's (WHO) COVAX alliance to equitably distribute COVID-19 vaccines across the world, China has stepped up the usage of its coronavirus vaccines to three more cities for urgent use. Three more cities in East China's Zhejiang Province are stepping up efforts to offer COVID-19 vaccines for urgent use, with priority being given to key groups in need before they can be rolled out to the general public, official media reports here said.

The cities of Yiwu, Ningbo and Shaoxing are targeting key groups with urgent need for vaccinations against COVID-19 following the city of Jiaxing, state-run Global Times quoted another daily, The Paper, as reporting on Saturday. Earlier on Thursday, health authorities in Jiaxing announced that the city has been administering inactivated COVID-19 vaccines among high-risk groups and will gradually offer it to ordinary citizens for urgent use.

According to the report, the emergency vaccinations have officially kicked off in Yiwu, an internationally renowned manufacturing hub. On Friday afternoon, about 20 people visited the community health centre to receive vaccinations against COVID-19 within an hour.

Most of the recipients are set to go abroad or have plans to go abroad in the near future, The Paper reported. The Yiwu health authorities said the COVID-19 shots have arrived in the local medical system and are limited to a small part of the population in need of emergency vaccination, including frontline medical staff, personnel who ensure the city's basic operation, and public officials who need to travel to high-risk countries and regions on official duties, the Global Times report said.

Yiwu also has no plans to make the vaccine available to the general public at the time, but may consider offering the vaccination to the public if there is an abundant supply when the vaccine is officially on the market, it said. China in a surprise move on October 9 joined the WHO's COVAX alliance to equitably distribute COVID-19 ending speculation that it plans to supply its vaccines to developing countries to improve its image dented by pandemic since it emerged in Wuhan in December last year.

All the 11 vaccines in China are in various stages of trials and await final approval. The COVAX is a global initiative aimed at working with vaccine manufacturers to provide countries worldwide equitable access to safe and effective vaccines, once they are licensed and approved.

China has roped in more than a dozen countries to conduct the final phase trials of Chinese-made experimental COVID-19 vaccines and even started vaccinating thousands of emergency workers. Yang Sheng, Deputy Director of the National Medical Products Administration's drug registration bureau, said earlier that four China-developed COVID-19 vaccines have begun the final stage of human trials overseas after obtaining approval from foreign authorities.

China has been focusing on developing five types of vaccines, and each method has at least one entering clinical trials. In total, 11 vaccine candidates are in different stages of testing, Yang has been quoted by the official media earlier.

Zheng Zhongwei, head of China's vaccine development task force, said China's annual capacity to make COVID-19 vaccines was expected to reach 610 million doses this year and one billion doses by 2021. The WHO said nine candidate vaccines are currently being evaluated for inclusion in the COVAX Facility.

They include two from China, two from the US, one from the Republic of Korea, one from Britain and Northern Ireland and one global, multi-manufacturer partnership. Two of these are in phase I trials, two are technology transfers and the remainder are at the discovery stage.

The coronavirus has so far claimed 4,634 lives with 85,672 confirmed infections in China.


TRENDING

OPINION / BLOG / INTERVIEW

New farm bills in India: Focusing on farms or farmers?

... ...

Kenya’s COVID-19 response: Chaos amid lack of information

Confusing numbers and scanty information on how effective curfews and lockdowns have been in breaking transmission have amplified coordination and planning challenges in Kenyas response to COVID-19. Without accurate data, it is impossible t...

Farkhad Akhmedov: Calculating the price of impunity from the law

In insistences such as the battle over the Luna, Akhmedov has resorted to extreme legal machinations to subvert the High Courts decision and keep his assets from being seized. ...

Guinea’s elections hearken back to the autocracy and violence of its past

... ...

Videos

Latest News

Thomas has a fast start for a 65 and a 1-shot lead at Zozo

Justin Thomas went from a fast finish one day to a fast start the next, and it carried him to a 7-under 65 and a one-shot lead in the Zozo Championship at Sherwood. Thomas wasnt particularly thrilled, except for his position, mainly because...

Washington state discovers first 'murder hornet' nest in US

Scientists in Washington state have discovered the first nest of so-called murder hornets in the United States and plan to wipe it out Saturday to protect native honeybees, officials said. Workers with the state Agriculture Department spent...

Trump to vote in Florida before hitting campaign trail, Biden heads to Pennsylvania

President Donald Trump will vote in his adopted home of Florida before holding campaign rallies in three swing states on Saturday, joining more than 53 million Americans who have cast early ballots at a record-setting pace ahead of the Nov....

BJP demands Mehbooba's arrest for 'seditious' remarks

The Jammu and Kashmir BJP has demanded PDP chief Mehbooba Muftis arrest for her seditious remarks, wherein she said she would only hold the tricolour when the flag of the erstwhile state is restored. The BJP said no power on earth can eithe...

Give Feedback